The Evolving Role of Stereotactic Body Radiation Therapy for Head and Neck Cancer: Where Do We Stand?
Cancers · 16.10.2023 · 15 (20) · 5010
DOI: 10.3390/cancers15205010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.10.2023. Verfasst von Issa Mohamad und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, King Hussein Cancer Center, Amman 11941, Jordan. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Stereotactic body radiation therapy (SBRT) is a precise and conformal radiation therapy (RT) that aims to deliver a high dose of radiation to the tumor whilst sparing surrounding normal tissue, making it an attractive option for head and neck cancer (HNC) patients who are not suitable for the traditional long course of RT with comprehensive RT target volume. Definitive SBRT for HNC has been investigated in different settings, including early stage glottis cancer, and as an alternative to brachytherapy boost after external beam RT. It is also used as a primary treatment option for elderly or medically unfit patients. More recently, an SBRT combination with immunotherapy in the neoadjuvant setting for HNC showed promising results. Salvage or adjuvant SBRT for HNC can be used in appropriately selected cases. Future studies are warranted to determine the optimum dose and fractionation schedules in any of these indications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, King Hussein Cancer Center, Amman 11941, Jordan.
- Department of Radiation Oncology, Odette Cancer Centre, University of Toronto, Toronto, ON M4N3M5, Canada.
- Faculty of Medicine, University of Toronto, Toronto, ON M5S1A1, Canada.
- Department of Radiation Oncology, Burjeel Medical City, Abu Dhabi 7400, United Arab Emirates.
- Emirates Oncology Society, Dubai 2299, United Arab Emirates.
- Department of Nuclear Medicine, King Hussein Cancer Center, Amman 11941, Jordan.
ORCID-Profile: Issa Mohamad, Akram Al-Ibraheem
Zitieren
APA
Mohamad, I., Karam, I., El-Sehemy, A., Abu-Gheida, I., Al-Ibraheem, A., Al-Assaf, H., Aldehaim, M., Alghamdi, M., Alotain, I., Ashour, M., Bushehri, A., ElHaddad, M., & Hosni, A. (2023). The Evolving Role of Stereotactic Body Radiation Therapy for Head and Neck Cancer: Where Do We Stand?. Cancers, 15(20), 5010. https://doi.org/10.3390/cancers15205010
Vancouver
Mohamad I, Karam I, El-Sehemy A, Abu-Gheida I, Al-Ibraheem A, Al-Assaf H, et al. The Evolving Role of Stereotactic Body Radiation Therapy for Head and Neck Cancer: Where Do We Stand?. Cancers. 2023;15(20):5010. doi:10.3390/cancers15205010
BibTeX
@article{Mohamad2023,
author = {Mohamad, Issa and Karam, Irene and El-Sehemy, Ahmed and Abu-Gheida, Ibrahim and Al-Ibraheem, Akram and Al-Assaf, Hossam and Aldehaim, Mohammed and Alghamdi, Majed and Alotain, Ibrahim and Ashour, May and Bushehri, Ahmad and ElHaddad, Mostafa and Hosni, Ali},
title = {The Evolving Role of Stereotactic Body Radiation Therapy for Head and Neck Cancer: Where Do We Stand?},
journal = {Cancers},
year = {2023},
volume = {15},
number = {20},
pages = {5010},
doi = {10.3390/cancers15205010}
}
EUVIMED